Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.00094 | 1 |
mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.00087 | 1 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.0033 | 1 |
mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.00046 | 1 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0024 | 1 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |